Mediclinic International PLC (LON:MDC)‘s stock had its “neutral” rating reiterated by equities research analysts at Citigroup Inc. in a research report issued on Tuesday.

A number of other equities research analysts also recently issued reports on MDC. Credit Suisse Group cut their target price on shares of Mediclinic International PLC from GBX 783 ($10.30) to GBX 630 ($8.29) and set a “neutral” rating for the company in a research report on Monday. Macquarie reiterated a “neutral” rating and issued a GBX 660 ($8.68) target price on shares of Mediclinic International PLC in a research report on Thursday, October 26th. Jefferies Group LLC reiterated an “underperform” rating and issued a GBX 550 ($7.23) target price on shares of Mediclinic International PLC in a research report on Friday, October 27th. Finally, J P Morgan Chase & Co downgraded shares of Mediclinic International PLC to a “neutral” rating and cut their target price for the stock from GBX 898 ($11.81) to GBX 733 ($9.64) in a research report on Thursday, October 19th. Two equities research analysts have rated the stock with a sell rating and seven have given a hold rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of GBX 701.44 ($9.23).

Shares of Mediclinic International PLC (LON:MDC) opened at GBX 538.50 ($7.08) on Tuesday. Mediclinic International PLC has a 12-month low of GBX 555.50 ($7.31) and a 12-month high of GBX 890.18 ($11.71).

WARNING: This piece was originally reported by Watch List News and is owned by of Watch List News. If you are reading this piece on another domain, it was illegally copied and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece can be viewed at https://www.watchlistnews.com/citigroup-inc-reaffirms-neutral-rating-for-mediclinic-international-plc-mdc/1716844.html.

Mediclinic International PLC Company Profile

Mediclinic International plc is an international private healthcare provider. The Company’s segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services. It has interest in Spire Healthcare, a United Kingdom-based private healthcare company.

Analyst Recommendations for Mediclinic International PLC (LON:MDC)

Receive News & Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.